INTS

INTENSITY THERAPEUTICS INC

• Reuters·03/31 11:15

  INTENSITY THERAPEUTICS INC <INTS.O>: BENCHMARK ADJUSTS TARGET PRICE TO $12 FROM $1.50 TO REFLECT REVERSE STOCK SPLIT

• Reuters·03/31 07:39

  U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

• TipRanks·03/30 20:00

  Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker

• TipRanks·03/30 11:30

  Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), IQVIA Holdings (IQV) and Xenon (XENE)

• TipRanks·03/29 06:01

  U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation

• Seeking Alpha·03/27 20:33

  Intensity Therapeutics GAAP EPS of -$8.56 misses by $0.69

• Benzinga·03/27 20:18

  Intensity Therapeutics Q4 EPS $(1.31) Misses $(0.04) Estimate

• Reuters·03/27 20:12

  INTENSITY THERAPEUTICS REPORTS 2025 YEAR END FINANCIAL RESULTS AND HIGHLIGHTS, AND PROVIDES CORPORATE UPDATE

• Reuters·03/27 20:02

  Intensity Therapeutics FY2025 net loss narrows 28.66% to $(11.6) million; operating expenses drop 27.81% to $12.0 million

• TipRanks·03/24 12:12

  Intensity Therapeutics issued new patent in the US

• Benzinga·03/24 12:09

  Intensity Therapeutics Issued New U.S. Patent Entitled 'A Method of Treating Cancer'

• Reuters·03/24 12:04

  Intensity Therapeutics wins US patent 12,496,345 for cancer treatment method

• TipRanks·03/23 20:43

  Intensity Therapeutics Expands ATM Equity Offering Capacity

• Benzinga·03/23 20:03

  Intensity Therapeutics Expands ATM Offering Capacity To $60M; May Issue Up To $60M Of Common Stock Under Offering Agreement

• Reuters·03/23 20:02

  INTENSITY THERAPEUTICS INC FILES FOR COMMON STOCK OFFERING OF UP TO $60 MLN - SEC FILING